Qian JH - Search Results

1

Segal DM, Qian JH, Titus JA, Moreno MB, George AJ, Jost CR, Kurucz I, el-Gamil M, Wunderlich JR. Segal DM, et al. Among authors: qian jh. Int J Cancer Suppl. 1992;7:36-8. Int J Cancer Suppl. 1992. PMID: 1428400 Review.

2

Targeting of anti-tumor responses with bispecific antibodies.

Segal DM, Qian JH, Mezzanzanica D, Garrido MA, Titus JA, Andrew SM, George AJ, Jost CR, Perez P, Wunderlich JR. Segal DM, et al. Among authors: qian jh. Immunobiology. 1992 Aug;185(2-4):390-402. doi: 10.1016/S0171-2985(11)80655-8. Immunobiology. 1992. PMID: 1452212 Review.

3

Cytokine release by peripheral blood lymphocytes targeted with bispecific antibodies, and its role in blocking tumor growth.

Segal DM, Qian JH, Andrew SM, Titus JA, Mezzanzanica D, Garrido MA, Wunderlich JR. Segal DM, et al. Among authors: qian jh. Ann N Y Acad Sci. 1991 Dec 30;636:288-94. doi: 10.1111/j.1749-6632.1991.tb33459.x. Ann N Y Acad Sci. 1991. PMID: 1793216 Review. No abstract available.

4

Human peripheral blood lymphocytes targeted with bispecific antibodies release cytokines that are essential for inhibiting tumor growth.

Qian JH, Titus JA, Andrew SM, Mezzanzanica D, Garrido MA, Wunderlich JR, Segal DM. Qian JH, et al. J Immunol. 1991 May 1;146(9):3250-6. J Immunol. 1991. PMID: 1826709

5

Effectors of targeted cellular cytotoxicity.

Segal DM, Garrido MA, Qian JH, Mezzanzanica D, Andrew S, Perez P, Kurucz I, Valdayo MJ, Titus JA, et al. Segal DM, et al. Among authors: qian jh. Mol Immunol. 1990 Dec;27(12):1339-42. doi: 10.1016/0161-5890(90)90040-7. Mol Immunol. 1990. PMID: 2274063 Review. No abstract available.

6

Targeting of cytotoxic cells against tumors with heterocrosslinked, bispecific antibodies.

Segal DM, Qian JH, Garrido MA, Perez P, Winkler DF, Wunderlich JR, Snider DP, Valdayo MJ, Titus JA. Segal DM, et al. Among authors: qian jh. Princess Takamatsu Symp. 1988;19:323-31. Princess Takamatsu Symp. 1988. PMID: 3269363

7

Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice.

Qian J, Dong Y, Pang YY, Ibrahim R, Berzofsky JA, Schiller JT, Khleif SN. Qian J, et al. Int J Cancer. 2006 Jun 15;118(12):3022-9. doi: 10.1002/ijc.21781. Int J Cancer. 2006. PMID: 16425257

8

Identification of H-2Db-specific CD8+ T-cell epitopes from mouse VEGFR2 that can inhibit angiogenesis and tumor growth.

Dong Y, Qian J, Ibrahim R, Berzofsky JA, Khleif SN. Dong Y, et al. J Immunother. 2006 Jan-Feb;29(1):32-40. doi: 10.1097/01.cji.0000175494.13476.56. J Immunother. 2006. PMID: 16365598

9

The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection.

Toubaji A, Hill S, Terabe M, Qian J, Floyd T, Simpson RM, Berzofsky JA, Khleif SN. Toubaji A, et al. Vaccine. 2007 Aug 1;25(31):5882-91. doi: 10.1016/j.vaccine.2007.05.040. Epub 2007 Jun 12. Vaccine. 2007. PMID: 17602804

10

Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells.

Zdanov S, Mandapathil M, Abu Eid R, Adamson-Fadeyi S, Wilson W, Qian J, Carnie A, Tarasova N, Mkrtichyan M, Berzofsky JA, Whiteside TL, Khleif SN. Zdanov S, et al. Cancer Immunol Res. 2016 Apr;4(4):354-65. doi: 10.1158/2326-6066.CIR-15-0241. Epub 2016 Feb 15. Cancer Immunol Res. 2016. PMID: 26880715 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters